| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 11/05/2008 | CN100430078C Rare earth-containing medicinal ointment for treating scald and injury |
| 11/05/2008 | CN100430075C Traditional Chinese medicine composition for treating mouth ulcer |
| 11/05/2008 | CN100430072C Chinese-medicinal preparation for treating cardiovascular and cerebrovascular diseases |
| 11/05/2008 | CN100430068C Chinese medicine for treating cardiomyopathy |
| 11/05/2008 | CN100430046C Composition and method for treating age-related disorders |
| 11/05/2008 | CN100429996C Antifatigue health product improving human body immunity function effectively and preparing method thereof |
| 11/04/2008 | US7446189 Use as vaccine adjuvants; useful in the treatment of autoimmune diseases and immunosuppression |
| 11/04/2008 | US7446179 CD19-specific chimeric T cell receptor |
| 11/04/2008 | US7445930 Method for the production and purification of adenoviral vectors |
| 11/04/2008 | US7445928 Bacterial artificial chromosome construct encoding recombinant coronavirus |
| 11/04/2008 | US7445798 Transgenic cells comprising nucleotide sequences coding fetal liver kinase-1 receptors; for use self-renewal of totipotent hematopoietic stem cell and to stimulate the development of all cells of the hematopoietic system both in vitro and in vivo |
| 11/04/2008 | US7445776 Mincing tissue, culturing with growth factors, bone morphogenetic protein or vitamin D; propagating in alginate, agarose and collagen to form 3-dimensional structure |
| 11/04/2008 | CA2325360C Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases |
| 11/04/2008 | CA2182890C Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells |
| 11/04/2008 | CA2136870C Anti-aids immunomodulation complex |
| 10/30/2008 | WO2008131006A2 Method for inhibiting scavenger receptor-a and increasing immune response to antigens |
| 10/30/2008 | WO2008131004A1 Telencephalic glial-restricted cell populations and related compositions and methods |
| 10/30/2008 | WO2008130100A1 Semi-mature dentritic cell |
| 10/30/2008 | WO2008130036A1 Method for production of antimutagenic substance using lactic acid bacterium |
| 10/30/2008 | WO2008129971A1 Improved persistently infective sendai virus vector |
| 10/30/2008 | WO2008129874A1 Method of targeting tumor cell and use of the same |
| 10/30/2008 | WO2008129841A1 Composition comprising lactic acid bacterium having high anti-allergic activity, and method for production of the lactic acid bacterium |
| 10/30/2008 | WO2008129802A1 Agent for lowering serum uric acid level and food or drink with indication of lowering serum uric acid level |
| 10/30/2008 | WO2008129554A1 Stem cell-derived retinal pigment epithelial cells |
| 10/30/2008 | WO2008129148A2 Use of lactobacillus casei for increasing the protection provided by the influenza vaccine |
| 10/30/2008 | WO2008128440A1 A series of recombinant adeno-associated viral vectors, construction methods and uses thereof |
| 10/30/2008 | WO2008128415A1 A medicine for improving quality of blood, preparation method and uses thereof |
| 10/30/2008 | WO2008105715A3 Use of lactobacillus plantarum for increasing bacterial diversity |
| 10/30/2008 | WO2008100498A3 Treatment of inflammatory diseases using placental stem cells |
| 10/30/2008 | WO2008057162A3 Native (telopeptide) placental collagen compositions |
| 10/30/2008 | WO2008039644A3 Compositions and methods for treating cancer |
| 10/30/2008 | WO2008030290A3 Novel dairy herd management methods |
| 10/30/2008 | WO2008002996A3 Rheumatoid arthritis t cell vaccine |
| 10/30/2008 | WO2007126805A8 Cancer immunotherapy compositions and methods of use |
| 10/30/2008 | US20080269666 Microneedles and Methods for Microinfusion |
| 10/30/2008 | US20080269473 Expression vector comprising nucleotide sequences coding gag and pol proteins for as tool in improving exogenous gene expression |
| 10/30/2008 | US20080269128 Albumin Fusion Proteins |
| 10/30/2008 | US20080269127 Albumin Fusion Proteins |
| 10/30/2008 | US20080269126 Albumin Fusion Proteins |
| 10/30/2008 | US20080269125 Albumin Fusion Proteins |
| 10/30/2008 | US20080268499 Nucleotide sequences coding hormone recptors for use in identifying modulaors of insect propagation; biological pest control; insecticides |
| 10/30/2008 | US20080268065 Functional food for ameliorating engogenous melatonin secretion rhythm and functional food for ameliorating circadian rhythm |
| 10/30/2008 | US20080268064 fractioning blood to produce a blood component, shaping the cartilage defect to expose subchondral bone, microfracturing the subchondral bone, and applying the blood component to the microfractured subchondral bone |
| 10/30/2008 | US20080268054 Dermal derived human stem cells and compositions and methods thereof |
| 10/30/2008 | US20080268052 exhibits an enhanced rate of polymerization and enhanced microstructural and mechanical properties upon polymerization |
| 10/30/2008 | US20080268016 Engineered Renal Tissue |
| 10/30/2008 | US20080268015 Methods and compositions for promoting localization of pharmaceutically active agents to bone |
| 10/30/2008 | US20080268012 Extracted demineralized bone matrix having osteoinductive activity |
| 10/30/2008 | US20080268007 Beauty/medication patch |
| 10/30/2008 | US20080268006 Probiotic Lactobacillus Strains for Improved Vaginal Health |
| 10/30/2008 | US20080267996 Compositions for inducing an immune response against hepatitis B |
| 10/30/2008 | US20080267994 in vitro culturing; producing immunostimulants for a specific immune response and individuals who suffer from HIV infection, certain cancers, allergies, have received transplants; Acute Myeloid Leukemia cancers treatments, and autoimmune diseases such as Systemic Lupus Erythematosus; anti-viral cytokines |
| 10/30/2008 | US20080267989 Self aggregating monomeric fusion protein for use in induction of immune response to human immunodeficiency viral infection |
| 10/30/2008 | US20080267972 Donor Lymphocyte Infusion of T Cells For the Treatment of Cancer |
| 10/30/2008 | US20080267969 Treatment of Pulmonary Hypertension Using an Agent That Inhibits a Tissue Factor Pathway |
| 10/30/2008 | US20080267967 Modulation of cd200 receptors |
| 10/30/2008 | US20080267962 Albumin Fusion Proteins |
| 10/30/2008 | US20080267961 SOLUBLE ErbB3 AND TREATMENT OF CANCER |
| 10/30/2008 | US20080267940 Using protamine to precipitate fibrinogen from whole blood; wound healing agent |
| 10/30/2008 | US20080267936 Treatment of trauma-hemorrhage with short oligopeptides |
| 10/30/2008 | US20080267935 Using mixture comprising cytosine arabinoside (AraC) and granulocyte macrophage colony stimulating factor immunotherapeutic to treat cell proliferative disorders; antitumor agents |
| 10/30/2008 | US20080267934 Use of Apoptotic Cells Ex Vivo to Generate Regulatory T Cells |
| 10/30/2008 | US20080267933 Using lactobacillus and/or bifidobacterium cultures to control weight gain, prevent obesity, increase satiety, prolong satiation, reduce food intake, reduce fat deposition, improve energy metabolism, enhance insulin sensitivity and treat insulin insensitivity |
| 10/30/2008 | US20080267931 Compositions for Silencing the Expression of Vdac1 and Uses Thereof |
| 10/30/2008 | US20080267930 Biological Materials and Uses Thereof |
| 10/30/2008 | US20080267929 Use of stem cells to generate inner ear cells |
| 10/30/2008 | US20080267928 Compositions and Methods for Making Insulin-Producing Cells |
| 10/30/2008 | US20080267927 Using electrical pulses and embryonic stem cell culture to enhance propagation of cardiac tissue; tissue engineering and repair; regenerative medicine |
| 10/30/2008 | US20080267926 Exposing embryonic stem cells culture to cells expressing activin receptor-like kinase (ALK) receptor, transplanting tissues into mammal, recovering insulin secreting cells; endocrine cell therapy |
| 10/30/2008 | US20080267925 Recovering beta-islet cells from pancreas of rabbits comprising: harvesting pancreas from newborn rabbits, placing in salt solution, mincing, removing destroyed cells, propagating beta-islet cells, transplant into mammal; treating pancreatic disorder; tissue engineering and repair; regenerative medicine |
| 10/30/2008 | US20080267924 Repairing tissue and reducing localized fluid retention after surgery via exposure to vascular endothelial growth factors before, during and after surgery; tissue repair |
| 10/30/2008 | US20080267923 Improving hair growth in human via administration of hair follicle growth-promoting cells to bald area |
| 10/30/2008 | US20080267922 Slitrks as markers for stem and progenitor cells and methods of use thereof |
| 10/30/2008 | US20080267920 Monoparamunity inducers based on attenuated rabbit myxomaviruses |
| 10/30/2008 | US20080267919 Solid support for initiating neovascularization; blood vessels fomation; targeted neovascularization; tissue target therapy |
| 10/30/2008 | US20080267902 Blood products with binding agent |
| 10/30/2008 | CA2686393A1 Composition comprising lactic acid bacterium having high anti-allergic activity, and method for production of the lactic acid bacterium |
| 10/30/2008 | CA2684647A1 Telencephalic glial-restricted cell populations and related compositions and methods |
| 10/30/2008 | CA2684460A1 Stem cell-derived retinal pigment epithelial cells |
| 10/30/2008 | CA2678004A1 Utilisation de lactobacillus casei pour renforcer la protection induite par la vaccination anti-grippale |
| 10/29/2008 | EP1985703A2 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 10/29/2008 | EP1985633A1 Kit of parts for the treatment of cancer or infectious diseases |
| 10/29/2008 | EP1985632A2 Use of VEGF2 antibodies for inhibiting photoreceptor cell proliferation |
| 10/29/2008 | EP1985320A1 A multi-formed collagenous biomaterial medical device |
| 10/29/2008 | EP1985293A1 Method for producing denatured substance of lactalbumin |
| 10/29/2008 | EP1985191A1 Preparation of polyfunctional fermented food products |
| 10/29/2008 | EP1984491A2 Methods and compositions for enhancing engraftment of hematopoietic stem cells |
| 10/29/2008 | EP1984490A1 Method for culturing cells derived from the adipose tissue and uses thereof |
| 10/29/2008 | EP1984007A1 Use of local immune suppression to enhance oncolytic viral therapy |
| 10/29/2008 | EP1984006A1 Conditioned blood composition and method for its production |
| 10/29/2008 | EP1983976A2 Composition comprising a polyunsaturated fatty acid for improving membrane composition |
| 10/29/2008 | EP1983849A1 A food composition comprising amino acids |
| 10/29/2008 | EP1789063A4 Tissue engineered meat for consumption and a method for producing tissue engineered meat for consumption |
| 10/29/2008 | EP1487285B9 Alertness bar |
| 10/29/2008 | EP1406650B1 Use of poly-glu, tyr for neuroprotection therapy of the cns or pns |
| 10/29/2008 | EP1402005B1 A method of purification of cells |
| 10/29/2008 | EP1317256B1 Pharmaceutical composition having modified carrier |
| 10/29/2008 | EP1313574B1 Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same |
| 10/29/2008 | EP1234044B1 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 10/29/2008 | EP1208217B1 Antibody dependent enhancement (ade) of alphavirus infection |